Literature DB >> 8175845

Failure of structural acetabular allografts in cementless revision hip arthroplasty.

J P Hooten1, C A Engh, C A Engh.   

Abstract

We investigated the radiographic and clinical course of 31 patients in whom a bulk acetabular allograft had been used during the cementless revision of a total hip replacement. Two patients died and two were lost to follow-up within 24 months, but of the remaining 27 acetabular components, 12 (44%) showed radiographic evidence of instability at a mean of 46 months. Five of these have been revised. In the 12 failures, signs of instability had been noted at an average of 29 months (1 to 60). Failures during the first 24 months were usually due to technical errors, later failures to gradual migration of the cup into the graft. The cups with the greatest amount of their surface supported by grafts were most likely to migrate, but this migration was usually asymptomatic. Screw fixation of the cup, used in 24 cases, appeared to control the mechanism of failure. Femoral head allografts and distal femoral allografts had been used, with failure in 6 of 16, and 6 of 11 respectively; distal femoral allografts were used only for large defects. The insidious course of late cup migration and graft failure necessitates close radiographic follow-up of patients treated with bulk allografts.

Entities:  

Mesh:

Year:  1994        PMID: 8175845

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  23 in total

1.  Large acetabular defects can be managed with cementless revision components.

Authors:  E Scott Paxton; James A Keeney; William J Maloney; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

2.  The survival and fate of acetabular reconstruction with impaction grafting for large defects.

Authors:  Eduardo Garcia-Cimbrelo; Ana Cruz-Pardos; Eduardo Garcia-Rey; José Ortega-Chamarro
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

3.  [Mega cups and partial pelvic replacement].

Authors:  R von Eisenhart-Rothe; H Gollwitzer; A Toepfer; H Pilge; B M Holzapfel; H Rechl; R Gradinger
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

4.  [Modular reconstruction in acetabular revision with antiprotrusio cages and metal augments : the cage-and-augment system].

Authors:  K-P Günther; T Wegner; S Kirschner; A Hartmann
Journal:  Oper Orthop Traumatol       Date:  2014-04-02       Impact factor: 1.154

5.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

6.  Structural allograft and primary press-fit cup for severe acetabular deficiency. A minimum 6-year follow-up study.

Authors:  F Traina; F Giardina; M De Clerico; A Toni
Journal:  Int Orthop       Date:  2005-04-05       Impact factor: 3.075

7.  Type III acetabular defect revision with bilobed components: five-year results.

Authors:  Joseph T Moskal; Michael E Higgins; Joseph Shen
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

8.  Metropolitan and micropolitan statistical area estimates of depression and anxiety using the Patient Health Questionnaire-8 in the 2006 Behavioral Risk Factor Surveillance System.

Authors:  Tara W Strine; Satvinder S Dhingra; Kurt Kroenke; Mohamed Qayad; James L Ribble; Catherine A Okoro; Lina S Balluz; Shanta R Dube; James Lando; Ali H Mokdad
Journal:  Int J Public Health       Date:  2009       Impact factor: 3.380

Review 9.  Acetabular reinforcement rings associated with allograft for severe acetabular defects.

Authors:  Emmanuel Gibon; Luc Kerboull; Jean-Pierre Courpied; Moussa Hamadouche
Journal:  Int Orthop       Date:  2018-09-13       Impact factor: 3.075

10.  [Reconstruction of large acetabular defects using trabecular metal augments].

Authors:  Olaf Hasart; Carsten Perka; Rex Lehnigk; Stephan Tohtz
Journal:  Oper Orthop Traumatol       Date:  2010-07       Impact factor: 1.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.